Based on the primary findings of this study, we have also preliminarily explored the potential of MAGI3 as a prognostic biomarker in other types of renal cancer, such as kidney renal papillary cell carcinoma and chromophobe renal cell carcinoma. The gene discussed is MAGI3; the disease is renal carcinoma.